Pharming Group N.V. (AMS:PHARM)

Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	964	977	627	690	707	503
Market Cap Growth	74.19%	55.71%	-9.08%	-2.41%	40.66%	-38.05%
Enterprise Value	910	947	587	658	657	487
Last Close Price	1.41	1.43	0.93	1.03	1.08	0.78
PE Ratio	397.00	402.37	-	-	55.27	35.75
Forward PE	53.01	-	-	163.65	27.10	16.92
PS Ratio	3.01	3.05	2.19	3.11	3.68	2.88
PB Ratio	4.08	4.14	2.94	3.49	3.69	2.96
P/TBV Ratio	8.00	8.10	4.06	5.17	5.82	5.23
P/FCF Ratio	20.98	21.26	-	-	35.85	21.10
P/OCF Ratio	20.69	20.97	-	-	33.66	15.11
EV/Sales Ratio	2.84	2.96	2.05	2.97	3.41	2.78
EV/EBITDA Ratio	24.24	25.59	188.69	-	40.97	18.22
EV/EBIT Ratio	32.51	34.49	-	-	67.70	23.07
EV/FCF Ratio	19.80	20.61	-	-	33.29	20.43
Debt / Equity Ratio	0.42	0.42	0.51	0.78	0.82	0.84
Debt / EBITDA Ratio	2.66	2.66	17.02	-	8.46	4.88
Debt / FCF Ratio	2.15	2.15	-	-	7.91	5.97
Net Debt / Equity Ratio	-0.23	-0.23	-0.25	-0.19	-0.20	-0.16
Net Debt / EBITDA Ratio	-1.46	-1.46	-17.24	2.74	-2.37	-0.99
Net Debt / FCF Ratio	-1.17	-1.17	21.50	2.24	-1.93	-1.11
Asset Turnover	0.84	0.84	0.69	0.55	0.50	0.49
Inventory Turnover	0.75	0.75	0.63	0.51	0.50	0.87
Quick Ratio	2.02	2.02	2.96	3.28	3.90	4.69
Current Ratio	2.59	2.59	3.77	4.06	4.65	5.33
Return on Equity (ROE)	1.02%	1.02%	-5.38%	-4.98%	6.88%	8.50%
Return on Assets (ROA)	4.48%	4.48%	-0.52%	-3.06%	1.57%	3.68%
Return on Invested Capital (ROIC)	2.87%	3.36%	-2.10%	-12.76%	5.79%	10.98%
Return on Capital Employed (ROCE)	8.40%	8.40%	-1.10%	-5.70%	2.80%	6.80%
Earnings Yield	0.25%	0.25%	-1.82%	-1.38%	1.81%	2.80%
FCF Yield	4.77%	4.70%	-0.40%	-2.46%	2.79%	4.74%
Buyback Yield / Dilution	-6.17%	-6.17%	-2.18%	7.09%	-0.85%	-2.70%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.